Td Waterhouse Canada Inc. Vanda Pharmaceuticals Inc. Transaction History

Td Waterhouse Canada Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Nov 13, 2023	SELL	$6.87 - $10.96 $3,455 - $5,512	-503 Closed	0 $0
Q3 2022 Nov 13, 2023	SELL	$9.44 - $11.76 $1,642 - $2,046	-174 Reduced 25.7%	503 $5.09 Million
Q2 2022 Nov 13, 2023	BUY	$9.31 - $11.84 $1,554 - $1,977	167 Added 32.75%	677 $7.56 Million
Q1 2022 Nov 13, 2023	BUY	$10.84 - $16.55 $1,886 - $2,879	174 Added 51.79%	510 $6.03 Million
Q4 2021 Nov 13, 2023	BUY	$15.69 - $21.14 $5,271 - $7,103	336 New	336 $5.47 Million

161

45.2M

165K

33.6K

Ticker VNDA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 56,561,500
Market Cap $274M
Description
Vanda Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of therapies to address high unmet medical needs. The company's marketed products include HETLIOZ for the treatment of non-24-hour sleep-wake disorders; and Fanapt oral tablets for the treatment of schizophrenia. Its products under developme...

Get notified when there are updates to the investment portfolio of Td Waterhouse Canada Inc., based on Form 13F filings with the SEC.

Stay updated on Td Waterhouse Canada Inc. with notifications on news.